EliseAI Doubles Valuation to $4 Billion in $350M Raise

EliseAI has raised $350 million at a $4 billion valuation, the company announced on Tuesday. The figure is double the worth the startup commanded when it raised its Series E last August.

Andreessen Horowitz and Bessemer Ventures co-led the round. The New York-based startup, founded in 2017, automates administrative and operational work for housing and healthcare companies.

The scale of adoption is notable. EliseAI said its software is used by 1 in 6 apartments across the United States. The company announced this summer that it passed $200 million in annual recurring revenue.

Apollo: an AI 'teammate' inside the platform

Earlier this month, EliseAI launched an AI agent called Apollo, designed to help with tasks inside the EliseAI platform. Because the product is embedded in software its customers already run, the company argues it can act across an entire property team's workflow.

"It's built natively into the same platform that already runs leasing, maintenance, and renewals," co-founder and CEO Minna Song told TechCrunch. "So it can act across every role on a property team."

That framing positions Apollo as more than a bolt-on chatbot. It operates where the company already handles core operations for property managers, from leasing inquiries to maintenance requests to lease renewals.

The healthcare expansion

On the healthcare side, EliseAI automates patient-related paperwork for specialty physician groups. The scope is broad.

"[It works] from the first inbound call through referrals, scheduling, insurance verification, chart prep, and follow-up, so nothing falls through the cracks," Song said.

The two sectors are not a random pairing. Song said the company targeted housing and healthcare because they are two of the "largest expenses for American households." Both industries share a common trait: heavy administrative burdens and large volumes of routine communication that sit at the edges of high-stakes services.

Why the valuation doubled

A doubled valuation in roughly a year is a strong signal in a funding market that has punished most AI-adjacent startups without clear revenue traction. EliseAI's $200 million ARR milestone, disclosed this summer, gave investors a concrete growth metric to underwrite. The company's penetration — one in six American apartments — suggests its housing product has moved well beyond early adopters.

The Apollo launch signals where the company goes next. If AI agents can act across leasing, maintenance and renewals within a single platform, EliseAI can deepen its footprint with existing customers rather than rely solely on new acquisition.

The healthcare vertical offers a parallel path. Automating the full patient intake pipeline — calls, referrals, insurance verification, chart preparation — addresses a documented pain point for specialty physician groups facing staffing constraints.

With $350 million in new capital and backing from two major venture firms, EliseAI now has the resources to push both fronts at once.